The recent rise in aged care stocks, led by Summerset (SUM) and Ryman Healthcare (RYM), is justified by improved housing sentiment, but further gains may be limited as SUM faces a transition year with increased net debt and lower earnings projections; resulting in a downgrade to NEUTRAL with a NZ$10.55 target price.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.